SCHEMBL573713

SCHEMBL573713

Oc1cccc(OCCCc2ccccc2)c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.63
DRD4 P21917 2/20 0.63
DRD3 P35462 2/20 0.63
ADRA1D P25100 1/20 0.63
ADRA1A P35348 1/20 0.63
ADRA1B P35368 1/20 0.63
CHRNB2 P17787 1/20 0.54
CHRNA4 P43681 1/20 0.54
AKR1B10 O60218 1/20 0.52
AKR1B1 P15121 1/20 0.52
FFAR1 O14842 2/20 0.51
MAOA P21397 3/20 0.51
MAOB P27338 3/20 0.51
SIRT2 Q8IXJ6 1/20 0.50
APP P05067 1/20 0.50
CYP4F2 P78329 1/20 0.50
CYP4A11 Q02928 1/20 0.50
BCHE P06276 1/20 0.50
OPRK1 P41145 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16528761 0.95 DRD2 (0.61) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL8765703 0.93 DRD2 (0.60) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL25197061 0.91 DRD2 (0.65) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL661821 0.91 DRD2 (0.65) DRD2DRD4DRD3ADRA1DADRA1A
Butylbenzyl SCHEMBL28097889 0.88 CNR2 (0.55) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL6910779 0.87 FFAR1 (0.60) DRD2DRD4DRD3ADRA1DADRA1A
Hydrochloric Acid SCHEMBL8053906 0.87 DRD2 (0.70) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL27260337 0.86 FFAR1 (0.54) DRD2DRD4DRD3FFAR1MAOA
SCHEMBL6912529 0.85 DRD2 (0.49) DRD2DRD4DRD3ADRA1DADRA1A
SCHEMBL10479366 0.83 DRD2 (0.63) DRD2DRD4DRD3ADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 608 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12053537-B2 Reduction of stinging sensation on skin SYMRISE AG (DE) 2024-08-06 US claimed
CN-108472220-B Reducing the perception of skin stinging 西姆莱斯股份公司 2022-06-17 CN claimed
EP-3373895-B1 REDUCTION OF STINGING SENSATION ON SKIN SYMRISE AG (DE) 2020-08-19 EP claimed
CN-104414869-B A kind of skin and/or hair whitening mixture 西姆莱斯股份公司 2019-09-03 CN claimed
EP-3373895-A1 REDUCTION OF STINGING SENSATION ON SKIN Symrise AG (DE) 2018-09-19 EP claimed
CN-108472220-A Reduce skin irritation impression 西姆莱斯股份公司 2018-08-31 CN claimed
EP-2842607-B1 A skin and/or hair whitening mixture SYMRISE AG (DE) 2018-05-30 EP claimed
WO-2017080625-A1 REDUCTION OF STINGING SENSATION ON SKIN SYMRISE AG (DE) 2017-05-18 WO claimed
CN-104414869-A SKIN AND/OR HAIR WHITENING MIXTURE SYMRISE AG 2015-03-18 CN claimed
US-20150064122-A1 SKIN AND/OR HAIR WHITENING MIXTURE SYMRISE AG (DE) 2015-03-05 US claimed
EP-1879457-A1 ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES Ciba Specialty Chemicals Holding, Inc. (CH) 2008-01-23 EP claimed
US-20070231295-A1 Antimicrobial Silicon Oxide Flakes CIBA SPECIALTY CHEMICALS CORP. 2007-10-04 US claimed
EP-1755381-A2 ANTIMICROBIAL SILICON OXIDE FLAKES CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-02-28 EP claimed
WO-2006120135-A1 ANTIMICROBIAL POROUS SILICON OXIDE PARTICLES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-11-16 WO claimed
US-20060040847-A1 Hard surface treating compositions RECKITT BENCKISER INC. 2006-02-23 US claimed
WO-2005107456-A2 ANTIMICROBIAL SILICON OXIDE FLAKES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-11-17 WO claimed
EP-1537201-A1 HARD SURFACE TREATING COMPOSITIONS Reckitt Benckiser Inc. (US) 2005-06-08 EP claimed
EP-0805672-B1 METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH HOMOLA ANDREW M (US) 2004-08-25 EP claimed
WO-2004024861-A1 HARD SURFACE TREATING COMPOSITIONS RECKITT BENCKISER INC (US) 2004-03-25 WO claimed
US-5665333-A Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth PROVSEAL LLC 1997-09-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12053537-B2 Reduction of stinging sensation on skin STING1, TYR, CUTA DRD2 2146/4885DRD4 2316/4885DRD3 1906/4885
US-20150064122-A1 SKIN AND/OR HAIR WHITENING MIXTURE TYR, AHR, CYP1B1 DRD2 515/4885DRD4 434/4885DRD3 264/4885
US-20070231295-A1 Antimicrobial Silicon Oxide Flakes SIK2, SIK3, SIK1 DRD2 2600/4885DRD4 1907/4885DRD3 2170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.